AVNS: Avanos Medical, Inc. - Summary | Jitta

Avanos Medical, Inc.

NYSE:AVNS

Price
$24.65
Loss Chance
50.8%
3.69JITTA SCORE
127.75%Over Jitta Line
Jitta Ranking
409 / 718
2,911 / 4,228
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (35)
Recent Business Performance (53)
Financial Strength (64)
Return to Shareholders (10)
Competitive Advantage (43)
Jitta Signs
Revenue and EarningEarning loss detected in 2023
Operating MarginDeclined
Recent Business PerformanceEarning decline 91.57% in the last year
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
3.69
127.75%
3.07
403.38%
Health Care Supplies
6.57
23.36%
4.84
432.84%
4.39
89.57%
COMPANY DESCRIPTION
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.